Blood test could lead to cystic fibrosis treatment tailored to each patient
Researchers have used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient's precise biology.
from Latest Science News -- ScienceDaily https://ift.tt/2LchVRr
from Latest Science News -- ScienceDaily https://ift.tt/2LchVRr
Comments
Post a Comment